NCT06300970View on ClinicalTrials.gov

Efficacy of Artesunate-amodiaquine and Artemether-lumefantrine for Treatment of Plasmodium Falciparum Malaria in Liberia

PHASE4CompletedINTERVENTIONAL
Enrollment

352

Participants

Timeline

Start Date

August 9, 2022

Primary Completion Date

August 16, 2023

Study Completion Date

August 16, 2023

Conditions
Plasmodium FalciparumMalariaUncomplicated Malaria
Interventions
DRUG

Amodiaquine-artesunate (ASAQ)

Oral medication given for treatment of uncomplicated plasmodium falciparum infection.

DRUG

Artemether+Lumefantrine (AL)

Oral medication given for treatment of uncomplicated plasmodium falciparum infection.

Trial Locations (2)

Unknown

Sinje Health Center, Garwula District, Sinje, Grand Cape Mount County, Sinje

Saclepea-Mahn Comprehensive Health Center Saclepea-Mahn District, Nimba County, Saclepea

All Listed Sponsors
collaborator

Ministry of Health, Liberia

OTHER

lead

Centers for Disease Control and Prevention

FED